Join
Live feed
·
PRReleasevia Quantisnow
Insmed Incorporated logo

Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension

ByQuantisnow·Wall Street's wire, on your screen.
INSM· Insmed Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INSM (Insmed Incorporated) and more on Quantisnow.